A. Wymenga

A new in vitro assay for quantitation of chemotherapy-induced mucositis.

N. Mulder, E. de Vries, W. Timens, 1997, British Journal of Cancer.

Topical lidocaine in silver sulfadiazine cream on painful, cancer, or treatment-related skin lesions.

A. Reyners, A. Wymenga, J. J. Meeuse, 2007, Journal of pain and symptom management.

Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.

F. Spijkervet, N. Mulder, E. de Vries, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells.

E. D. de Vries, W. Timens, F. Burlage, 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism

E. Vries, A. Wymenga, N. Mulder, 1999, Bone Marrow Transplantation.

A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.

E. D. de Vries, A. Wymenga, G. H. van der Linden, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

H. Boezen, P. Nieboer, E. Vries, 2009, Breast Cancer Research and Treatment.

1209 Studies on vitality of oral epithelial cells during and after high-dose chemotherapy; a new assay for quantitation of chemotherapy-induced mucositis

F. Spijkervet, W. Timens, E. Vries, 1995 .

Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms.

E. D. de Vries, E. Van Cutsem, M. Välimäki, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Soft tissue sarcoma: why not treated?

H. Hoekstra, A. Wymenga, R. Otter, 2005, Critical reviews in oncology/hematology.

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study.

W. M. Smit, H. Hollema, P. Willemse, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.